ArticleSmall science2021
Beyond Platinum: Defects Abundant CoP
Article in Small science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Charge Steering in Heterojunction Photocatalysis: General Principles, Design, Construction, and Challenges.Small science · 2023Article
- A Janus heteroatom-doped carbon electrocatalyst for hydrazine oxidation.National science review · 2023Article
- Small-Scale Big Science: From Nano- to Atomically Dispersed Catalytic Materials.Small science · 2022Article
- Structural Regulation of Pd-Based Nanoalloys for Advanced Electrocatalysis.Small science · 2021Article
- Energy-saving hydrogen production by chlorine-free hybrid seawater splitting coupling hydrazine degradation.Nature communications · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Water electrolysis is a promising option for pure hydrogen production, but it is limited by the high cost. Developing superb and low-cost electrocatalysts for hydrogen evolution reaction (HER) is critical for cost reduction. Heterostructures are demonstrated with excellent HER activities, but still inferior to commercial Pt/C. Herein, vacancy type of defects is engineered into the interface of CoP
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.